Posted on Jul 6, 2015 3:30:00 PM by Rebecca Anderson

Selecting Treatment for OAB Patients

Who Can Benefit from Urgent PC Treatment? 

Diverse group of adultsAn estimated 42 million people suffer from the symptoms of overactive bladder (OAB), often with frustrating results. It’s not just the inconvenience of having to go to the bathroom all the time or the embarrassment of accidents. Many people are also frustrated when their prescribed first and second line treatments under-deliver on results and over-deliver on side-effects. Consequently, a majority of OAB patients stop taking their OAB drugs within 90 days and 80% discontinue their medication within a year.  If that’s not cause enough for an alternate treatment, consider the recent report in the Journal of the American Medical Association (JAMA) which noted a link between anticholinergics and an increased risk of dementia in elderly patients.

Percutaneous tibial nerve stimulation (PTNS) via the Urgent PC Neuromodulation System is a proven option for patients who do not or cannot achieve their treatment goals with OAB medications. Urgent PC is a drug-free, office-based OAB treatment that provides results in up to 80% of patients. The question then becomes, which patients are candidates for Urgent PC?

  • 46-year-old male, business professional who travels 5-6 times per month. His most bothersome symptom is urgency and he says that about 2-3 times per week he has difficulty getting to the bathroom in time. He is also in the bathroom at least three times a night.  He is on his third drug and is seeing some reduction in his night-time voids but his urgency hasn’t improved. 
  • 72-year-old grandmother of seven sings in the church choir three times per week. Medical issues include arthritis pain, hypertension, cholesterol, acid reflux and more. Uses the bathroom 15-20 times a day and has concerns about leakage or wetting herself.  She doesn’t want to take another drug since she already takes so many.
  • 78-year-old male must use the bathroom more than twice a night and experiences episodes of urgency, frequency, leaking and wetting accidents.  He has limited his out of house activities for fear of not getting to the bathroom in time. Was unresponsive to behavioral and drug therapy.
  • 50-year-old mother, who successfully recovered from brain surgery, but was left with incontinence due to bladder overactivity. Currently uses six pairs absorbent underwear each day. Had a failed SNS implant and doesn’t want to undergo the procedure again.
  • A 59-year-old female, who uses the bathroom at least 20-times per day and frequently at night. Difficulty sitting for long periods without immediate access to a bathroom. Had intradetrusor botulinumtoxinA injections 1 year ago but suffered from retention. She’s looking for another option.

Although these cases involve both male and female patients from different age groups and lifestyles, all of them are candidates for PTNS Therapy via Urgent PC. Unlike many of the other therapies available including OAB drugs and other 3rd line procedures, Urgent PC is very low risk with no severe adverse events.

OAB is rarely just a minor inconvenience. It’s a set of life-altering symptoms that virtually handcuff patients to their homes or the nearest bathroom. There is a long list of research indicating the efficacy of Urgent PC therapy. Coupled with its adverse event profile, selecting the right patient is no longer a bigger challenge than actually treating the condition.

Urgent PC eBook CTA

Urgent PC is indicated for the treatment of Overactive Bladder and associated symptoms of urinary urgency, urinary frequency and urge incontinence. Treatment with Urgent PC is contraindicated for patients with pacemakers or implantable defibrillators, patients prone to excessive bleeding, patients with nerve damage that could impact either percutaneous tibial nerve or pelvic floor function or patients who are pregnant or planning to become pregnant during the duration of the treatment. Most patients don't experience side-effects. If side-effects occur, they are typically temporary and include mild pain and skin inflammation at or near the stimulation site. Caution: Federal law (USA) restricts this device to sale by or on the order of a physician. For complete instructions for use, storage, warnings, indications, contraindications, precautions, adverse reactions and disclaimer of warranties, please refer to the insert accompanying each product or online at www.cogentixmedical.com. Urgent PC is a registered trademark of Cogentix Medical © 2015 Cogentix Medical. All rights reserved. 

Rebecca Anderson
Rebecca Anderson has been a marketer in the healthcare industry for over fifteen years, the last ten of which have been focused on Urgent PC and other products from Cogentix Medical. Rebecca has a special fondness for Urgent PC, having been part of the Uroplasty team that launched the product to U.S. and International markets.
Return To Blog